Instrumentation Laboratory Acquires CA Casyso
By LabMedica International staff writers Posted on 26 Sep 2016 |
Instrumentation Laboratory (IL) (Bedford, MA, USA), which manufactures instruments and reagents for the global hemostasis market, has acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a provider of in vitro diagnostic (IVD) testing for patient blood management (PBM).
CA Casyso AG is the parent company of Tem Innovations, Tem International and Tem Systems, while IL is a part of the Werfen family of companies. Tem manufactures Rotem whole blood analyzers, which detect coagulopathies in hospital trauma and surgical patients with clinically significant bleeding to allow treatment with targeted therapy, thereby minimizing or preventing massive bleeding and hemorrhagic shock. The acquisition of CA Casyso AG and Tem will allow IL to complement and expand their leadership in hemostasis and critical care IVD through the product line in viscoelastic testing.
"A passion for innovation, leading systems and extensive knowledge in PBM, make Tem a perfect complement to our focus, commitment, and leadership in Hemostasis and Critical Care IVD," said Ramon Benet, CEO at IL. "IL and our global Werfen organizations are ideally positioned to maximize the potential of the ROTEM product line, which intersects our existing business and presents synergies in our core competencies and customer call points. Most importantly, ROTEM systems share the same ultimate benefit of all our products -- to help customers reduce overall hospital costs, while improving patient care."
Related Links:
Instrumentation Laboratory
CA Casyso AG is the parent company of Tem Innovations, Tem International and Tem Systems, while IL is a part of the Werfen family of companies. Tem manufactures Rotem whole blood analyzers, which detect coagulopathies in hospital trauma and surgical patients with clinically significant bleeding to allow treatment with targeted therapy, thereby minimizing or preventing massive bleeding and hemorrhagic shock. The acquisition of CA Casyso AG and Tem will allow IL to complement and expand their leadership in hemostasis and critical care IVD through the product line in viscoelastic testing.
"A passion for innovation, leading systems and extensive knowledge in PBM, make Tem a perfect complement to our focus, commitment, and leadership in Hemostasis and Critical Care IVD," said Ramon Benet, CEO at IL. "IL and our global Werfen organizations are ideally positioned to maximize the potential of the ROTEM product line, which intersects our existing business and presents synergies in our core competencies and customer call points. Most importantly, ROTEM systems share the same ultimate benefit of all our products -- to help customers reduce overall hospital costs, while improving patient care."
Related Links:
Instrumentation Laboratory
Latest Industry News
- Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
- Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance